NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1
Walden University NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1 –Step-By-Step Guide
This guide will demonstrate how to complete the Walden University NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1 assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.
How to Research and Prepare for NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1
Whether one passes or fails an academic assignment such as the Walden University NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1 depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.
After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.
How to Write the Introduction for NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1
The introduction for the Walden University NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1 is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.
Need a high-quality paper urgently?
We can deliver within hours.
How to Write the Body for NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1
After the introduction, move into the main part of the NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1 assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.
Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.
How to Write the Conclusion for NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1
After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.
How to Format the References List for NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1
The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.
Stuck? Let Us Help You
Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.
Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1 assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.
Sample Answer for NRNP 6552 Week 4 Common Gynecologic Conditions, Part 1
Case 1: Debbie
Outline Subjective data.
| Outline Objective findings.
| Identify diagnostic tests, procedures, and laboratory work indicated.
| Distinguish at least three differential diagnoses. | Identify appropriate medications, treatments, or other interventions associated with each differential diagnosis. | Explain key Social Determinants of Health (SDoH) for your chosen case. | Describe collaborative care referrals and patient education needs for your chosen case. |
The patient presents with mild lower abdominal pain with substantial vaginal discharge over the past week. The patient has had four sexual partners in the past six months and has a medical history that includes depressive disorders, HSV-2, and a previous surgical abortion. She is now using Loestrin Fe for contraception and has a regular menstrual cycle, with her most recent period happening two weeks prior. Socially, she lives with her parents, refutes drug usage, has completed high school, and is employed as a waitress. Her familial background includes a mother with depression. Further information is required about her sexual activities, the features of her vaginal discharge, specifics about her depression and HSV-2 care, contraception use, and understanding of Pap smears (Dombrowski, 2021). | The patient’s vital signs are stable: blood pressure is 112/80 mmHg, pulse is 72 bpm, respiration rate is 16 bpm, temperature is 98.4°F, weight is 110 pounds, height is 54 inches, and BMI is 18.9 kg/m². The overall look is robust and well-fed, with no indications of distress. The abdominal examination indicates a soft, non-tender, and non-distended abdomen, devoid of masses or organ hypertrophy. The gynecological examination reveals no lesions or substantial abnormalities; nonetheless, slight cervical motion pain is seen. Further laboratory tests are required, including NAAT for chlamydia and gonorrhea (Dombrowski, 2021). | Debbie’s symptoms and medical history need a thorough evaluation. The Nucleic Acid Amplification Test (NAAT) for Chlamydia and Gonorrhea is advised for detecting the pathogens responsible for these illnesses. At the same time, wet mount and KOH testing of vaginal discharge may assist in diagnosing bacterial vaginosis, trichomoniasis, along with yeast infections (Dombrowski, 2021). A Pap smear is advised for cervical cancer screening, whereas a PCR test may verify a herpes simplex virus infection in the presence of visible lesions. Pelvic ultrasonography may identify structural abnormalities, ovarian cysts, or other etiologies of abdominal discomfort. A CBC may detect markers of infection or anemia, while a urinalysis can exclude a UTI to distinguish between gynecological and gastrointestinal symptoms. The American College of Obstetricians and Gynecologists (ACOG) endorses these diagnostic tools for women suffering from abdominal pain. | Chlamydia Trachomatis is the most frequently identified STD in the US, especially among young people and adolescents who are sexually active (Davidson et al., 2021). Debbie’s symptoms, characterized by mucopurulent cervical discharge and cervical friability, align with a chlamydial infection. The CDC’s STI Treatment Guidelines emphasize the need for screening for chlamydia in sexually active individuals. Gonorrhea is a prevalent sexually transmitted infection with similar symptoms, and the CDC advises concurrent treatment for chlamydia in those presenting with cervicitis and a history of many sexual partners (Van Ommen et al., 2023). Bacterial Vaginosis (BV) is the predominant cause of vaginal discharge in women of reproductive age, often presenting as a homogeneous, off-white, thin discharge accompanied by a fishy odor. Debbie’s account of significant vaginal discharge suggests the potential of BV, and ACOG acknowledges its common occurrence and manifestation via discharge, warranting attention even in the absence of typical symptoms. | For the treatment of Chlamydia Trachomatis infection, patients may administer either 1 g of azithromycin or 100 mg of doxycycline bi-daily for seven days, with a strong focus on completing the whole antibiotic regimen (Davidson et al., 2021). The prescribed therapy for gonorrhea is a single intramuscular dosage of 500 mg of Ceftriaxone for those weighing < 150 kg, accompanied by 1 g of oral azithromycin (Van Ommen et al., 2023). The CDC recommends dual medication to avoid co-infection with chlamydia and address antibiotic resistance. Treatment alternatives for BV are Clindamycin cream 2% administered intravaginally at night for seven days, Metronidazole gel 0.75% applied intravaginally once daily for five days, or Metronidazole 500 mg taken orally twice daily for seven days (Coudray & Madhivanan, 2020). Patients are instructed to refrain from douching and using harsh soaps and to recognize the impact of several sexual partners on vaginal flora and the heightened risk of BV (Chacra et al., 2022). | Debbie, a waitress exhibiting signs of an STI, is affected by many SDOH. Her work, education, and socioeconomic level might influence her health literacy, comprehension of health risks, and access to healthcare services. Her little earnings may restrict her capacity to finance routine gynecological examinations, contraceptives, and therapies. Financial constraints may also impede her compliance with treatment protocols and access to therapy. Moreover, her insufficient access to comprehensive sexual education may impair her understanding of STI prevention, contraceptive use, and the need for regular gynecological treatment. Education, cultural norms, and access to resources such as condoms and contraceptive services influence her sexual health practices. Consequently, her health condition, access to healthcare, and possible health outcomes are all affected by these variables (Francisco-Natanauan et al., 2021). | A comprehensive strategy that includes targeted patient education and coordinated care referrals is necessary to treat Debbie’s health challenges properly. It is advisable to send her to a gynecologist or an infectious disease expert for accurate diagnosis and treatment of suspected STIs and comprehensive gynecological evaluations. Furthermore, considering her history of depression, a referral to mental health services is essential for managing her emotional well-being, perhaps improving her receptiveness to medical counsel. Social services may address socioeconomic obstacles, while a patient navigator can facilitate access to essential resources. Additionally, Debbie necessitates instruction on sexual health, encompassing safe sex practices and the relevance of STI screening, along with comprehensive details about her treatment strategy and the essential of follow-up care to ensure efficient infection resolution and avert problems (Francisco-Natanauan et al., 2021). |
References
Chacra, L. A., Fenollar, F., & Diop, K. (2022). Bacterial vaginosis: What do we currently know? Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.672429
Coudray, M. S., & Madhivanan, P. (2020). Bacterial vaginosis—A brief synopsis of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 143–148. https://doi.org/10.1016/j.ejogrb.2019.12.035
Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Simon, M. A., Stevermer, J., Tseng, C., & Wong, J. B. (2021). Screening for chlamydia and gonorrhea. JAMA, 326(10), 949. https://doi.org/10.1001/jama.2021.14081
Dombrowski, J. C. (2021). Chlamydia and gonorrhea. Annals of Internal Medicine, 174(10), ITC145–ITC160. https://doi.org/10.7326/aitc202110190
Francisco-Natanauan, P., Leatherman-Arkus, N., & Pantell, R. H. (2021). Chlamydia and Gonorrhea Prevalence and treatment in Detained Youths: Strategies for improvement. Journal of Adolescent Health, 68(1), 65–70. https://doi.org/10.1016/j.jadohealth.2020.09.041
Van Ommen, C. E., Malleson, S., & Grennan, T. (2023). A practical approach to the diagnosis and management of chlamydia and gonorrhea. Canadian Medical Association Journal, 195(24), E844–E849. https://doi.org/10.1503/cmaj.221849